Clinical trial

Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin

NCT01422590

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE1

Study timeline

Study start (unknown)2010-05-01Date precision: month

Registry last updated2011-09-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

MitiglinideDRUG

Sitagliptin, MitiglinideDRUG

Sponsors & collaborators

Samsung Medical Centerlead sponsor

JW Pharmaceuticalcollaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01422590 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.